0050 GMT - NRW Holdings' bull at UBS thinks the market is overestimating the impact of contractual work at Northern Star's Fimiston project ending in October. UBS assumes a 10% on-year revenue decline in FY27 within NRW's MET division. "We think risk is likely to the upside, with no shortage of work being locked in across Primero, RCR, DIAB and OFI," says UBS, naming several NRW businesses. Looking beyond the near term, UBS thinks there could be meaningful upside from the potential commercialization and widespread take-up of Primero's 'Ali' lithium processing technology. "With 18% EPS compound annual growth over the next 3 years and likely upside risk from topline continuing to be topped up from contact award momentum, we view 11.4x FY27 Ebita as undemanding," UBS says of NRW's stock. (david.winning@wsj.com; @dwinningWSJ)
(END) Dow Jones Newswires
July 12, 2026 20:50 ET (00:50 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments